Immunocore Holdings Stock Buy Hold or Sell Recommendation
| IMCR Stock | USD 28.80 0.53 1.87% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Immunocore Holdings is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Immunocore Holdings within the specified time frame.
Check out Immunocore Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide. Note, we conduct extensive research on individual companies such as Immunocore and provide practical buy, sell, or hold advice based on investors' constraints. Immunocore Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Immunocore |
Execute Immunocore Holdings Buy or Sell Advice
The Immunocore recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Immunocore Holdings. Macroaxis does not own or have any residual interests in Immunocore Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Immunocore Holdings' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Immunocore Holdings Trading Alerts and Improvement Suggestions
| The company reported the previous year's revenue of 310.2 M. Net Loss for the year was (51.09 M) with profit before overhead, payroll, taxes, and interest of 299.7 M. | |
| Immunocore Holdings has a poor financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Needham Company LLC Reaffirms Buy Rating for Immunocore |
Immunocore Holdings Returns Distribution Density
The distribution of Immunocore Holdings' historical returns is an attempt to chart the uncertainty of Immunocore Holdings' future price movements. The chart of the probability distribution of Immunocore Holdings daily returns describes the distribution of returns around its average expected value. We use Immunocore Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Immunocore Holdings returns is essential to provide solid investment advice for Immunocore Holdings.
| Mean Return | -0.11 | Value At Risk | -4.18 | Potential Upside | 4.79 | Standard Deviation | 2.53 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Immunocore Holdings historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Immunocore Stock Institutional Investors
The Immunocore Holdings' institutional investors refer to entities that pool money to purchase Immunocore Holdings' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Armistice Capital, Llc | 2024-12-31 | 1.2 M | Fiera Capital Corporation | 2024-12-31 | 780 K | Citigroup Inc | 2024-12-31 | 632.9 K | Two Sigma Advisers, Llc | 2024-12-31 | 604.9 K | Groupama Asset Management | 2024-12-31 | 600 K | Millennium Management Llc | 2024-12-31 | 573.4 K | Deep Track Capital, Lp | 2024-12-31 | 519.4 K | Principal Financial Group Inc | 2024-12-31 | 502.9 K | Massachusetts Financial Services Company | 2024-12-31 | 459 K | T. Rowe Price Investment Management,inc. | 2024-12-31 | 6.7 M | Wellington Management Company Llp | 2024-12-31 | 6.6 M |
Immunocore Holdings Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Capital Expenditures | 3.1M | 1.0M | 2.2M | 5.4M | 5.2M | 3.7M | |
| Change To Netincome | 3.4M | 33.3M | 45.4M | 22.1M | 25.4M | 26.7M | |
| Investments | 467K | (367K) | 193K | 4.8M | (355.1M) | (337.4M) | |
| Change In Cash | 55.8M | 146.0M | 114.3M | 40.2M | 13.1M | 12.4M | |
| Depreciation | 9.0M | 7.0M | 6.1M | 4.1M | 4.2M | 5.0M | |
| Net Income | (74.1M) | (131.5M) | (41.2M) | (43.4M) | (51.1M) | (53.6M) | |
| End Period Cash Flow | 129.7M | 321.1M | 401.6M | 442.6M | 455.7M | 279.4M | |
| Free Cash Flow | (63.6M) | (130.8M) | (33.5M) | (2.5M) | 20.9M | 21.9M | |
| Other Non Cash Items | 38.5M | (14.9M) | (7.4M) | 4.0M | (6.4M) | (6.1M) |
Immunocore Holdings Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immunocore Holdings or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immunocore Holdings' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immunocore stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.42 | |
σ | Overall volatility | 2.51 | |
Ir | Information ratio | -0.0024 |
Immunocore Holdings Volatility Alert
Immunocore Holdings exhibits very low volatility with skewness of 0.19 and kurtosis of -0.22. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immunocore Holdings' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immunocore Holdings' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Immunocore Holdings Fundamentals Vs Peers
Comparing Immunocore Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Immunocore Holdings' direct or indirect competition across all of the common fundamentals between Immunocore Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as Immunocore Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Immunocore Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing Immunocore Holdings by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Immunocore Holdings to competition |
| Fundamentals | Immunocore Holdings | Peer Average |
| Return On Equity | -0.14 | -0.31 |
| Return On Asset | -0.0408 | -0.14 |
| Profit Margin | (0.16) % | (1.27) % |
| Operating Margin | (0.02) % | (5.51) % |
| Current Valuation | 1.05 B | 16.62 B |
| Shares Outstanding | 50.07 M | 571.82 M |
| Shares Owned By Insiders | 5.23 % | 10.09 % |
| Shares Owned By Institutions | 94.01 % | 39.21 % |
| Number Of Shares Shorted | 7.42 M | 4.71 M |
| Price To Book | 3.98 X | 9.51 X |
| Price To Sales | 4.65 X | 11.42 X |
| Revenue | 310.2 M | 9.43 B |
| Gross Profit | 299.7 M | 27.38 B |
| EBITDA | (70.46 M) | 3.9 B |
| Net Income | (51.09 M) | 570.98 M |
| Cash And Equivalents | 208.06 M | 2.7 B |
| Cash Per Share | 4.74 X | 5.01 X |
| Total Debt | 41.71 M | 5.32 B |
| Debt To Equity | 0.41 % | 48.70 % |
| Current Ratio | 3.98 X | 2.16 X |
| Book Value Per Share | 7.21 X | 1.93 K |
| Cash Flow From Operations | 26.06 M | 971.22 M |
| Short Ratio | 38.58 X | 4.00 X |
| Earnings Per Share | (1.02) X | 3.12 X |
| Target Price | 64.03 | |
| Number Of Employees | 493 | 18.84 K |
| Beta | 0.8 | -0.15 |
| Market Capitalization | 1.44 B | 19.03 B |
| Total Asset | 1.01 B | 29.47 B |
| Retained Earnings | (795.76 M) | 9.33 B |
| Working Capital | 717.68 M | 1.48 B |
| Net Asset | 1.01 B |
Note: Acquisition by Travis Coy of 274033 shares of Immunocore Holdings at 29.5 subject to Rule 16b-3 [view details]
Immunocore Holdings Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Immunocore . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Immunocore Holdings Buy or Sell Advice
When is the right time to buy or sell Immunocore Holdings? Buying financial instruments such as Immunocore Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Immunocore Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.